Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $27,971.00 |
|---|---|
| Enterprise Value | $-4,110,337.00 |
| Earnings per Share | $-4.56 |
| Beta | 0.8 |
| Outstanding Shares | 39,390 |
| P/E Ratio | -0.26 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 130.25%▼ 129662.43% |
|---|---|
| Total Invested | $83,116▼ 93.01% |
| Investors Holding | 4▼ 3.00% |
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company d...